ArticleFrontiers in medicine2025
Uplift modeling to determine which fluid-norepinephrine regime results in a postoperative acute kidney injury-free recovery in patients scheduled for cystectomy and urinary diversions.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative acute kidney injury (PO-AKI) remains common after surgery. Although risk prediction models for PO-AKI exist, it is still unknown which intraoperative regime in terms of fluid and norepinephrine administration is beneficial for a specific patient. We thus aim to investigate the potential of uplift modeling-a framework combining causal inference and machine learning-in identifying patients for which certain fluid and norepinephrine regimes result in a PO-AKI-free recovery. Methods: Data from a prospectively maintained cystectomy database at a single tertiary center ( Results: The uplift models demonstrated a higher ability (AUQC: 0.30, 95%-CI: 0.26-0.30) compared to a random sorting strategy (0.06, 95%-CI: 0.02-0.06) or a traditional prediction model (AUQC: 0.06, 95%-CI: 0.03-0.06) for PO-AKI in sorting patients according to the expected treatment benefit from either a high TIFB / low NE or a low TIFB / high NE regime. The performance of the uplift models is robust with respect to the fluid-NE dichotomization. Conclusion: Uplift modeling provides a clinically relevant step toward personalized medicine by considering the incremental benefit of an alternative treatment versus a control treatment on a patient's outcome, thus moving from a predictive toward a prescriptive risk assessment. We demonstrated the overall higher clinical utility of an uplift modeling approach compared to a prediction model of baseline PO-AKI risk in sorting patients according to the expected treatment benefit from either a high total intraoperative fluid balance / low norepinephrine regime or a low total intraoperative fluid balance / high norepinephrine regime with respect to postoperative acute kidney injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.